确定CTH和MAP1LC3B作为ferroptosis生物标志物,用于胃癌解码的预后指示
Haishun Qu1, Yunxiao Liang1, Quan Guo1
1Guangxi Academy of Medical Sciences, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Scientific reports
|February 22, 2024
概括
通过识别新的生物标志物,可以改善胃癌 (GC) 的预后. 这项研究发现,囊胺-酶 (CTH) 和微管相关蛋白1光链3β (MAP1LC3B) 水平,以及免疫细胞的变化,预测患者的生存率.
科学领域:
- 在瘤学瘤学.
- 生物标志物发现发现
- 癌症基因组学 癌症基因组学
背景情况:
- 胃癌 (GC) 由于其高发病率和不良预后,对全球健康构成了重大挑战.
- 可靠的预后生物标志物对于改善患者结果和指导GC治疗策略至关重要.
研究的目的:
- 通过生物信息学分析识别胃癌的新型预后生物标志物.
- 为了研究与铁亡相关的基因,免疫细胞透和GC患者存活率之间的关系.
主要方法:
- 利用癌症基因组图谱 (TCGA) 数据库进行GC患者数据分析.
- 采用单变量和多变量考克斯回归,包括LASSO回归,以开发预后模型.
- 使用CIBERSORT量化免疫细胞亚型,并探索与基因表达 (CTH,MAP1LC3B) 的相关性.
- 通过免疫组织化学分析验证生物信息学的发现.
主要成果:
- 开发了一种综合氨酸玛酶 (CTH) 和微管相关蛋白1光链3β (MAP1LC3B) 的预后模型.
- 通过模型识别的高风险患者的生存率显著降低.
- CTH表达与单细胞水平相反相关;MAP1LC3B表达与M2巨细胞丰度相反相关.
- 与对照人群相比,免疫组织化学证实GC组织中的CTH和MAP1LC3B表达率较低.
结论:
- CTH,MAP1LC3B和相关的单细胞-巨细胞动态是GC预后的潜在关键因素.
- 这些已识别的元素为胃癌的预后评估和治疗干预提供了有希望的目标.
- 这项研究强调了生物信息学在发现新型癌症生物标志物的有用性.
更多相关视频
09:16Detection of a CDH1 Rare Transcript Variant in Fresh-frozen Gastric Cancer Tissues by Chip-based Digital PCR
Published on: February 5, 2018
6.2K
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
11.1K
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K